Update: Vertex Pharmaceuticals Says Journavx Non-Opioid Pain Killer Added to Optum Formulary
I'm PortAI, I can summarize articles.
Vertex Pharmaceuticals announced that its non-opioid pain killer, Journavx, has been added to UnitedHealth Group's Optum Rx formulary. This addition highlights the need for new treatment options for acute pain. Optum Rx is currently evaluating the clinical data for Journavx and has placed it on a "non-preferred" tier, indicating it will be covered but may be more expensive than preferred options. Journavx received FDA approval in January for treating moderate-to-severe acute pain.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Trading View The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments